VENROCK MANAGEMENT III LLC

CIK 00012392477 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001239247

Recent Transactions

35 trades

Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−41,270→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−1,031→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+15,446→ 47,077 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+214,820→ 214,820 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−142,607→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−25,233→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+139,019→ 423,754 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−32,086→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,009,414→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+227,117→ 275,450 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+41,270→ 1,265,504 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+48,333→ 48,333 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+9,285→ 284,735 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−3,563→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−227,117→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,009,414→ 1,224,234 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,031→ 31,631 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+5,367→ 5,367 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−9,285→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+617,868→ 1,883,372 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+25,233→ 30,600 total
Purchase
SIRNA THERAPEUTICS INC
Common Stock
2005-07-06$1.60/sh+1,000,000→ 6,038,805 total
Purchase
SIRNA THERAPEUTICS INC
Warrants (right to buy)
2005-07-06+360,000→ 360,000 total
Purchase
SIRNA THERAPEUTICS INC
Warrant (right to buy)
2005-06-30+950,093→ 950,093 total
Other
SIRNA THERAPEUTICS INC
Warrant (right to buy)
2005-06-30−950,093→ 0 total
Exercise of In-Money
SIRNA THERAPEUTICS INC
Common Stock
2004-12-30$2.52/sh+863,721→ 5,038,805 total
Exercise of In-Money
SIRNA THERAPEUTICS INC
Warrant (right to buy)
2004-12-30−863,721→ 0 total
Other
SIRNA THERAPEUTICS INC
Warrant (right to buy)
2004-12-30+950,093→ 950,093 total
Other
SIRNA THERAPEUTICS INC
Warrant (right to buy)
2004-12-30−863,721→ 0 total
Conversion
RENOVIS INC
Common Stock
2004-02-10+406,992→ 909,873 total
Conversion
RENOVIS INC
Series E Preferred Stock
2004-02-10−2,400,000→ 0 total
Conversion
RENOVIS INC
Common Stock
2004-02-10+499,253→ 502,881 total
Conversion
RENOVIS INC
Common Stock
2004-02-10+533,333→ 1,443,206 total
Conversion
RENOVIS INC
Series B Preferred Stock
2004-02-10−2,246,642→ 0 total
Conversion
RENOVIS INC
Series C Preferred Stock
2004-02-10−1,831,466→ 0 total

Companies

Recent Filings

4
Vitae Pharmaceuticals, Inc
Oct 1, 2014

Address

530 FIFTH AVENUE 22ND FLOOR

NEW YORK, NY, 10036

View on SEC.gov